C1 inhibitor hinge region mutations produce dysfunction by different mechanisms
- 1 August 1992
- journal article
- research article
- Published by Springer Nature in Nature Genetics
- Vol. 1 (5), 354-358
- https://doi.org/10.1038/ng0892-354
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Structural basis of latency in plasminogen activator inhibitor-1Nature, 1992
- Antithrombin Vicenza, Ala 384 to Pro (GCA to CCA) mutation, transforming the inhibitor into a substrateBritish Journal of Haematology, 1991
- Molecular characterization of antithrombin III (ATIII) variants using polymerase chain reaction. Identification of the ATIII Charleville as an Ala 384 Pro mutation.Journal of Clinical Investigation, 1989
- Antithrombin Cambridge, 384 Ala to Pro: A new variant identified using the polymerase chain reactionFEBS Letters, 1989
- Hormone binding globulins undergo serpin conformational change in inflammationNature, 1988
- A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.Journal of Clinical Investigation, 1988
- α 2 -Antiplasmin Enschede: Alanine Insertion and Abolition of Plasmin Inhibitory ActivityScience, 1987
- Plakalbumin, α1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosisNature, 1985
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- On the size of the active site in proteases. I. PapainBiochemical and Biophysical Research Communications, 1967